Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last year, primarily driven by higher growth in international ...
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product ...
Q4 2025 earnings call recap: revenue growth, 2026 guidance, Simeox & CPAP expansion, margins, and $30M buyback—read key takeaways.
Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsLorna Williams - Senior Vice President of Investor ...
Delivered full year revenue growth of approximately 4%. Significantly improved profitability with 2025 net loss of $22.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results